US 12084504
Anti-MET antibodies and uses thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 12084504 (Anti-MET antibodies and uses thereof) held by AGOMAB THERAPEUTICS expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AGOMAB THERAPEUTICS
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P1/04